Global Oxygen Therapy Market Outlook, Trends Analysis, Market Size, Insights

Global Oxygen Therapy Market Outlook 2016-2024

Market Overview

The air we intake comprises of 21% oxygen, whilst 21% is sufficient for people with healthy lungs but not enough for people with chronic lung conditions like COPD. That’s why oxygen therapy (O2 therapy) comes into play. The delivery mode and device used for oxygen therapy depends upon various factors like patient’s specific requirements and the instructions of the medical professionals. Philips Respironics is the most prescribed sleep therapy system in the U.S. by sleep physicians.

Goldstein Research analyst forecast that oxygen therapy market size is set to reach USD 2.75 billion by 2024, at a CAGR of 5.5% over the forecast years.

Covered In This Global Oxygen Therapy Market Report

The report covers the present ground scenario and the future growth prospects of the Oxygen Therapy market for 2016-2024. We calculated the market size and revenue share on the basis of revenue generated from the sales of oxygen therapy equipment from major players and the prevalence of respiratory, cardiovascular, sleep apnea, pneumonia incidences across the globe.

Global Oxygen Therapy - Market Segmentation

By Product Type

• Compressed Oxygen
• Liquid Oxygen
• Oxygen Concentrates

By Device

• Hyperbaric Oxygen Chamber
• Nasal Cannula
• Face mask

• Venturi Mask
• Non-rebreather Mask
• Bag Valve mask
• CPAP Mask

• Trans-tracheal therapy

By Diseases

• Respiratory Disorder
  • Asthma
  • Dysplasia-Pacific
  • Cystic Fibrosis
  • COPD (Chronic Obstructive Pulmonary Disease)
• Cardiovascular Disease
• Pneumonia
• Sleep Apnea
• Others

By End User

• Hospitals
• Clinics
• Ambulatory Centers
• Rehab Centers
• Home Healthcare

By Geography

• North America (U.S. & Canada) Oxygen Therapy Market
• Latin America (Brazil, Mexico, Argentina & Rest of Latin America) Oxygen Therapy Market
• Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) Oxygen Therapy Market
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) Oxygen Therapy Market
• Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Oxygen Therapy Market

On the basis of disease type, respiratory disorders serve as the catalyzers of the market which accounted for 47.5% market share in 2016 of total oxygen therapy market. Sleep apnea holds the promising future of oxygen therapy market owing to the increasing incidences of sleeping disorders across the globe.

Oxygen Therapy Market Outlook 2016-2024, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global oxygen therapy market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

Our global Oxygen Therapy market report comprises of the following companies as the key players in the Oxygen Therapy market: Respironics, Inc., Fisher & Paykel Healthcare Limited, Teleflex Incorporated, Invacare Corporation, AirSep Corporation, CareFusion Corporation, DeVilbiss Healthcare, MAQUET Holding B.V. & Co. KG, and ResMed, Inc.

According to our global market study on the basis of extensive primary and secondary research:  “One of the growing trend of oxygen therapy market is the advent of portable and wearable oxygen therapy devices like DreamStation by Philips offers performance to help improve the OSA therapy.”

According to the report, major driver for expansion of oxygen therapy market is growing air pollution, particularly in developing countries including China, India, Brazil, etc. and rising prevalence of COPD, Acute Asthma and other inveterate respiratory diseases. Total deaths due to the COPD is projected to increase by 30% in next 10 years, making COPD the third most fatal diseases worldwide, therefore driving the consumer base for oxygen therapy market.

Further, the report states that one challenge in oxygen therapy market is Hyperbaric Oxygen Therapy (HBOT) has not attained widespread approval in mainstream medicine. Even though HBOT has more FDA approved indications than any other medical treatment, it remains marginalized in conventional medicine with often a perception of “treatment of last resort”.

Based on geography, North America holds the largest market share of 35% in 2016 while APAC is projected to witness the growth with a CAGR of 5.67% over the forecast years. APAC is the opportunistic market owing to increase in geriatric population requiring home-based oxygen therapy, and rising healthcare expenditure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Oxygen Therapy report

• What is the total market size by 2024 and what would be the expected growth rate of the market?
• What is the shipments of Oxygen Therapy in 2015-16 and what would be the expected demand over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.